CRISIL Ltd. Valuation Adjusts Amid Shifting Market Dynamics

Valuation Metrics Signal Moderation

As of 30 Sep 2026, CRISIL’s P/E ratio stands at 36.99, a figure that, while still elevated, marks a downgrade from its previous very expensive classification. The price-to-book value ratio remains high at 10.00, underscoring the premium investors are willing to pay relative to the company’s net asset value. These multiples contrast with peer companies such as CARE Ratings, which holds a P/E of 27.71 and is classified as very expensive, and ICRA, with a P/E of 21.00, deemed expensive.

The enterprise value to EBITDA (EV/EBITDA) ratio for CRISIL is 26.14, higher than CARE Ratings’ 23.51 and significantly above ICRA’s 14.69, indicating that CRISIL commands a premium valuation on operational earnings as well. The PEG ratio of 1.72 suggests moderate growth expectations priced into the stock, higher than CARE Ratings’ 1.14 but lower than ICRA’s 1.86.

Price Movement and Market Capitalisation

CRISIL’s current market price is ₹4,474.40, down 3.76% on the day from a previous close of ₹4,649.20. The stock has traded within a 52-week range of ₹3,689.00 to ₹5,060.00, indicating significant volatility but also resilience in maintaining a high valuation band. The company is classified as a small-cap, which often entails higher volatility and growth potential compared to large-cap peers.

Despite the recent price dip, CRISIL’s year-to-date return of 3.45% outperforms the Sensex’s negative 14.89% return over the same period, highlighting relative strength in a challenging market environment. Over longer horizons, CRISIL has delivered impressive returns, with a 5-year gain of 64.91% compared to Sensex’s 22.08%, and a 10-year return of 105.69%, albeit below the Sensex’s 160.64% over the same period.

Financial Performance and Return Ratios

CRISIL’s return on capital employed (ROCE) is a robust 40.16%, reflecting efficient utilisation of capital to generate earnings. Return on equity (ROE) stands at 27.03%, signalling strong profitability relative to shareholder equity. These metrics underpin the company’s ability to sustain premium valuations despite recent market pressures.

The dividend yield of 1.41% offers a modest income stream to investors, consistent with the company’s growth-oriented profile. Enterprise value to capital employed (EV/CE) at 11.95 and EV to sales at 7.79 further illustrate the premium valuation placed on CRISIL’s operational scale and revenue generation.

Comparative Valuation Within Capital Markets Sector

Within the Capital Markets sector, CRISIL’s valuation remains on the higher side relative to peers. CARE Ratings, despite being classified as very expensive, trades at a lower P/E and EV/EBITDA multiple. ICRA, also expensive, offers a more moderate valuation profile. This suggests that CRISIL’s premium is justified by its superior return ratios and market positioning but also signals limited margin for further multiple expansion.

Investors should note that the downgrade in CRISIL’s mojo grade from Buy to Hold on 28 Sep 2026 reflects this valuation recalibration. The mojo score of 64.0 aligns with a Hold rating, indicating that while the company remains fundamentally sound, the current price levels warrant caution.

Market Sentiment and Price Dynamics

The recent 3.76% decline in CRISIL’s share price on 30 Sep 2026 reflects a broader market correction and investor reassessment of valuation premiums. The stock’s intraday range between ₹4,443.00 and ₹4,644.85 indicates volatility but also a potential support zone near current levels.

While the 52-week high of ₹5,060.00 remains a distant target, the stock’s resilience relative to the Sensex’s underperformance year-to-date suggests underlying confidence in CRISIL’s business model and growth prospects. However, the elevated valuation multiples imply that further upside may be constrained unless earnings growth accelerates materially.

Investment Outlook and Considerations

CRISIL’s transition from very expensive to expensive valuation status signals a more cautious stance for investors. The company’s strong fundamentals, including high ROCE and ROE, support its premium pricing, but the current multiples leave limited margin for error. Investors should weigh the company’s consistent performance against the risk of valuation compression in a volatile market environment.

Given the Hold mojo grade and the downgrade from Buy, a prudent approach would be to monitor earnings updates and sector developments closely. Comparisons with peers such as CARE Ratings and ICRA provide useful benchmarks for assessing relative value and growth potential within the Capital Markets sector.

Conclusion

CRISIL Ltd. remains a fundamentally strong company with a solid track record of returns and operational efficiency. However, the recent shift in valuation parameters from very expensive to expensive reflects a moderation in price attractiveness. Elevated P/E and P/BV ratios, combined with a Hold mojo grade, suggest that investors should exercise caution and consider alternative opportunities within the sector or broader market.

Long-term investors may find value in CRISIL’s consistent earnings and market positioning, but near-term price appreciation could be limited without a catalyst to justify multiple expansion.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →